Mon, Jul 28, 2014, 7:13 AM EDT - U.S. Markets open in 2 hrs 17 mins

Recent

% | $
Click the to save as a favorite.

Neurocrine Biosciences Inc. Message Board

  • networthdev networthdev Sep 2, 2013 2:26 PM Flag

    NBIX, Deutsche Bank raises PT to $25

    Google article title if interested in full story, "Deutsche Bank Increases Neurocrine Biosciences Price Target to $25.00 (NBIX)"

    Over the next 12 months we see four key catalysts that will provide upside to Neurocrine shares: Kinect Ph2, Kinect2 Ph2, Kinect safety, & Elagolix ph3 topline results. We also believe the opportunity for Elagolix in uterine fibroids (UF) is underappreciated. We have increased our probabilities for Elagolix in endometriosis (75% to 85%), VMAT2 (25% to 50%) to reflect trialsuccesses over next 12 mo & raised Elagolix UF estimates. Maintain Buy.,” Deutsche Bank’s analyst commented.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NBIX
13.53-0.14(-1.02%)Jul 25 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.